Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.22.4
STOCKHOLDERS' EQUITY (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 11, 2022
shares
Oct. 06, 2022
shares
Mar. 30, 2022
individual
shares
May 18, 2021
individual
issuer
shares
May 31, 2022
USD ($)
company
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock grants (in shares) 18,284 20,000 7,500 1,031,500          
Number of individuals     1 56          
Number of companies acquired | company         2        
Business acquisition consideration expected amount | $         $ 26,588,000        
Payments to acquire subsidiaries | $               $ 13,630,000  
Capital contributions | $           $ 0   677,000 $ 1,966,000
Stock-based compensation expense | $           $ 3,945,000 $ 4,561,000 $ 10,746,000 $ 11,283,000
Executive Officer                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of individuals | individual       2          
Key Employee                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock grants (in shares) 8,000                
Share-based payment arrangement, tranche one                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock grants (in shares)   4,000 3,000 200,942          
Vesting period (in years)       1 year          
Share-based payment arrangement, tranche two                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock grants (in shares)   4,000 1,500 211,658          
Vesting period (in years)       2 years          
Share-based payment arrangement, tranche three                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock grants (in shares)   4,000 1,500 206,300          
Vesting period (in years)       4 years          
Share-based payment arrangement, tranche three | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period (in years)       3 years          
Share-based payment arrangement, tranche three | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period (in years)       5 years          
Share based compensation award tranche four                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock grants (in shares)   4,000 1,500            
Share based compensation award tranche five                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Restricted stock grants (in shares)   4,000              
Freedom Life                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of voting interests acquired         100.00%        
Freedom Insurance                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of voting interests acquired         100.00%